EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Antibacterial and antifungal drug concentrations in intra-abdominal abscesses: a prospective clinical study

Alicia Cancela Costa, Fabian Grass, Ignacio Andres Cano, Florian Desgranges, Constant Delabays, Antonios Kritikos, Emmanouil Glampedakis, Thierry Buclin, Rafael Duran, Benoit Guery iD, Jean-Luc Pagani, Emilie Uldry und 2 weitere

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01178-24 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Alicia Cancela Costa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Service of Infectious Diseases, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antifungal Agents, Abdominal Abscess. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secondary peritonitis with intra-abdominal abscesses (IAA) is difficult to treat because of the supposed low rate of penetration of antimicrobial drugs at the site of infection. However, clinical data about the actual bioavailability of antimicrobial drugs in IAA are scarce. This prospective observational study aimed at assessing the drug penetration in IAA of the antibiotics (piperacillin-tazobactam, carbapenems) and antifungals (fluconazole, echinocandins) that are usually recommended for the treatment of intra-abdominal infections. Patients with IAA who underwent a radiological or surgical drainage procedure were included. Antimicrobial drug concentrations were measured in IAA (C IAA ) and in a simultaneous plasma sample (C plasma ) to assess the C IAA /C plasma ratio. The pharmacodynamic target was defined as a C IAA equal or superior to the clinical breakpoints of susceptibility of the most relevant intra-abdominal pathogens. Clinical outcomes were assessed at hospital discharge. A total of 54 antimicrobial drug measurements were performed in 39 IAA samples originating from 36 patients. Despite important inter-individual variability, piperacillin-tazobactam exhibited the highest C IAA /C plasma ratios (median 2). The rates of target achievement were 75%–80% for piperacillin-tazobactam and meropenem but 0% for imipenem and ertapenem. These results tended to correlate with clinical outcomes (96% success rate versus 73%, respectively, P = 0.07). Among antifungals, fluconazole exhibited higher C IAA /C plasma ratios and rates of target achievement compared to echinocandins. However, no differences in clinical outcomes were observed. These results provide unique information about antimicrobial drug penetration in IAA in real clinical conditions and suggest that piperacillin-tazobactam and meropenem may have better efficacy compared to imipenem or ertapenem.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAntifungal AgentsAbdominal AbscessHumansProspective StudiesFemaleMaleMiddle AgedPiperacillin, Tazobactam Drug CombinationAgedMicrobial Sensitivity TestsAdultPiperacillinMeropenemCarbapenemsPenicillanic AcidFluconazoleImipenemErtapenembeta-LactamsPeritonitis

Stichwörter der Autor:innen

anidulafunginbioavailabilitycaspofunginertapenemfluconazoleimipenemmeropenemperitonitispiperacillinsurgical

Substanzen

Anti-Bacterial AgentsAntifungal AgentsPiperacillin, Tazobactam Drug CombinationPiperacillinMeropenemCarbapenemsPenicillanic AcidFluconazoleImipenemErtapenem

Autor:innen und Institutionen

  • Service of Infectious Diseases, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Visceral Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Radiology and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Service and Laboratory of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Adult Intensive Care Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Institute of Microbiology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

ORCID-Profile: Benoit Guery, Laurent Arthur Decosterd, Frederic Lamoth

Zitieren

APA

Cancela Costa, A., Grass, F., Andres Cano, I., Desgranges, F., Delabays, C., Kritikos, A., Glampedakis, E., Buclin, T., Duran, R., Guery, B., Pagani, J. L., Uldry, E., Decosterd, L. A., & Lamoth, F. (2025). Antibacterial and antifungal drug concentrations in intra-abdominal abscesses: a prospective clinical study. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01178-24

Vancouver

Cancela Costa A, Grass F, Andres Cano I, Desgranges F, Delabays C, Kritikos A, et al. Antibacterial and antifungal drug concentrations in intra-abdominal abscesses: a prospective clinical study. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01178-24

BibTeX
@article{CancelaCosta2025,
  author = {Cancela Costa, Alicia and Grass, Fabian and Andres Cano, Ignacio and Desgranges, Florian and Delabays, Constant and Kritikos, Antonios and Glampedakis, Emmanouil and Buclin, Thierry and Duran, Rafael and Guery, Benoit and Pagani, Jean-Luc and Uldry, Emilie and Decosterd, Laurent Arthur and Lamoth, Frederic},
  title = {Antibacterial and antifungal drug concentrations in intra-abdominal abscesses: a prospective clinical study},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01178-24}
}
Kostenlos starten →